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Curcumin, the constituent of Curcuma longa, is considered a very promising anticancer agent due to its potent and
pleiotropic antineoplastic activity and low nonspecific toxicity to normal cells. However the clinical realization of its
potential has been limited due to its poor aqueous solubility and very low systemic bioavailability. A possible aproach
to overcome these limitations is the design of nanosized vechicles of curcumin.
The present work reports the preparation, characterization and in vitro evaluation of antineoplastic
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Formulations IC50 (μmol/L) (n=8)
KG-1a RPMI-8226b
Curcumin (DMSO solution) 13,45  2,31 2,89  0,77
Liposomal-PEG-CX-4 curcumin 2,19  0,71 0,59  0,21
PEG-CX-4 curcumin complexes 8,70  1,44 2,22  0,79
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Pro-apoptotic activity of free curcumin, liposomal-
PEG-CX-4 (CURC-LIPO)curcumin and PEG-CX-4 
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Parameter Heating method Solvent evaporation 
method
Stability constant (Kc) 325 µM
-1.ml 1072  µM-1.ml
Solubility enhancement 
factor (δ)*
40 960 % 59 445 %
Phosphorus content 
recovery
Size distribution of  
curcumin loaded 
DPPC liposomes
Size distribution of 
CX[4]arene:curcumi
n loaded DPPC 
liposomes.























































































DPPC: CHOL 124  4.2 0.096  0.002 -22 - -
DPPC: CHOL:CURC 145  3.6 0.14  0.04 -26.3 98 240
DPPC: CHOL:CURC:
CX[4]arene:curcumin
147  4.2 0.135  0.08 -20,8 82 345
Cytotoxicity study
CONCLUSION: Thus on the grounds of the excellent in vitro biocompatibility
profile and the favorable physicochemical and drug loading characteristics of the
tested liposomal nanoparticles, and their ability to retain the instirsnic
pharmacological properties of encapsulated drug they could be considered
promising drug delivery platforms for lipophilic curcumin.
